Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Baseline cellular HIV DNA load predicts HIV DNA decline and residual HIV plasma levels during effective antiretroviral therapy.
Parisi SG, Andreis S, Mengoli C, Scaggiante R, Ferretto R, Manfrin V, Cruciani M, Giobbia M, Boldrin C, Basso M, Andreoni M, Palù G, Sarmati L. Parisi SG, et al. Among authors: cruciani m. J Clin Microbiol. 2012 Feb;50(2):258-63. doi: 10.1128/JCM.06022-11. Epub 2011 Nov 30. J Clin Microbiol. 2012. PMID: 22135262 Free PMC article.
A stable CC-chemokine receptor (CCR)-5 tropic virus is correlated with the persistence of HIV RNA at less than 2.5 copies in successfully treated naïve subjects.
Parisi SG, Andreis S, Mengoli C, Scaggiante R, Cruciani M, Ferretto R, Manfrin V, Panese S, Basso M, Boldrin C, Bressan S, Sarmati L, Andreoni M, Palù G. Parisi SG, et al. Among authors: cruciani m. BMC Infect Dis. 2013 Jul 11;13:314. doi: 10.1186/1471-2334-13-314. BMC Infect Dis. 2013. PMID: 23844927 Free PMC article.
Strong and persistent correlation between baseline and follow-up HIV-DNA levels and residual viremia in a population of naïve patients with more than 4 years of effective antiretroviral therapy.
Parisi SG, Sarmati L, Andreis S, Scaggiante R, Cruciani M, Ferretto R, Manfrin V, Basso M, Andreoni M, Mengoli C, Palù G. Parisi SG, et al. Among authors: cruciani m. Clin Microbiol Infect. 2015 Mar;21(3):288.e5-7. doi: 10.1016/j.cmi.2014.10.009. Epub 2014 Oct 29. Clin Microbiol Infect. 2015. PMID: 25658542 Free article.
Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapy.
Mengoli C, Andreis S, Scaggiante R, Cruciani M, Bosco O, Ferretto R, Leoni D, Maffongelli G, Basso M, Torti C, Sarmati L, Andreoni M, Palù G, Parisi SG. Mengoli C, et al. Among authors: cruciani m. J Antimicrob Chemother. 2017 Jan;72(1):220-226. doi: 10.1093/jac/dkw348. Epub 2016 Sep 7. J Antimicrob Chemother. 2017. PMID: 27605599
Decreasing trends of drug resistance and increase of non-B subtypes amongst subjects recently diagnosed as HIV-infected over the period 2004-2012 in the Veneto Region, Italy.
Parisi SG, Andreis S, Scaggiante R, Cruciani M, Ferretto R, Manfrin V, Panese S, Rossi MC, Francavilla E, Boldrin C, Dal Bello F, Basso M, Mengoli C, Andreoni M, Palù G. Parisi SG, et al. Among authors: cruciani m. J Glob Antimicrob Resist. 2013 Dec;1(4):201-206. doi: 10.1016/j.jgar.2013.05.008. Epub 2013 Jul 27. J Glob Antimicrob Resist. 2013. PMID: 27873613
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitors.
Andreis S, Basso M, Scaggiante R, Cruciani M, Ferretto R, Manfrin V, Panese S, Rossi MC, Francavilla E, Boldrin C, Alvarez M, Dal Bello F, Mengoli C, Turriziani O, Sarmati L, Antonelli G, Andreoni M, Palù G, Parisi SG. Andreis S, et al. Among authors: cruciani m. J Glob Antimicrob Resist. 2017 Sep;10:106-112. doi: 10.1016/j.jgar.2017.05.011. Epub 2017 Jul 18. J Glob Antimicrob Resist. 2017. PMID: 28732792
221 results